A study reveals ... the Pfizer-Bionic vaccine is effective against the mutated Corona strain

Today, Friday, a recent medical study revealed that the "Pfizer-Biontech" vaccine is effective against the mutated Corona strain, which appeared in Britain and South Africa.

The study, which has not yet been reviewed, and conducted by scientists from the University of Texas in America in cooperation with "Pfizer", indicated that the vaccine for the American company has proven effective in neutralizing the mutation in the coronavirus, known as "N501Y".

"Reuters" quoted the chief viral vaccine scientist at Pfizer, Phil Dormitzer, as saying that the mutation "could be responsible for increasing the transmissibility of the disease, and there were concerns that it might make the virus escape from the antibodies produced by the vaccine."

Dormitzer added, "It is encouraging that the vaccine appears to be effective against the mutation, in addition to the 15 other mutations that Pfizer tested against."

He continued, saying, "We have now tested 16 different mutations, and none of them had any significant effect.

Scientists reached their results after conducting a study on blood taken from people who received the vaccine, but their results are limited, because they do not look at the full set of mutations present in any One of the new variants of the virus is the rapidly spreading virus.

The researchers plan to run similar tests to see if the vaccine is effective against other mutations found in the variants in the UK and South Africa, and they hope to have more data within weeks, according to Sky News.

Scientists have expressed concern that the vaccines that are being introduced may not be able to protect against new mutations, especially those that have appeared in South Africa.

Commenting on this, Simon Clark, assistant professor of cellular microbiology at the University of Reading, said that while both variants have some new features in common, the type found in South Africa "contains a number of additional mutations" that include modifications. More comprehensive.

It is worth noting that the "Pfizer-Biontech" vaccine, which was developed by "Moderna", is rapidly adjustable to treat any new mutations that may occur to the virus if necessary.

Follow our latest local and sports news, and the latest political and economic developments via Google news